查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1963663

皮膚強化劑市場：全球產業分析、規模、佔有率、成長、趨勢和預測（2025-2032）

Skin Boosters Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
出版日期: | 出版商: Persistence Market Research | 英文 174 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

主要發現：

  • 皮膚強化劑市場規模（2025年預測）：14.8億美元
  • 預計市場規模（2032年）：33.3億美元
  • 全球市場成長率（2025年至2032年複合年成長率）：12.3%

皮膚強化劑市場研究範圍：

全球皮膚強化劑市場涵蓋了透過微注射透明質酸和其他生物相容性化合物來改善皮膚水潤度、彈性和光澤的創新美容療法。這些微創療法，包括中美塑療法和微針療法，正日益被世界各地的皮膚科診所和醫療美容機構所採用。人們對外表日益成長的關注、對抗衰老解決方案的需求以及非手術美容療法正在推動市場擴張。

市場成長促進因素：

全球皮膚美容市場受多種關鍵因素驅動。消費者對護膚和美容健康的日益重視，以及可支配收入的增加，推動了他們對微創美容療法的需求。透明質酸、聚脫氧核苷酸（PDRN）、聚左旋乳酸（PLLA）、聚己內酯（PCL）和外泌體等生物相容性成分的進步，提高了治療的有效性和安全性，促進了其更廣泛的應用。此外，消費者越來越傾向於非手術療法而非傳統手術，這也推動了各地區（尤其是北美和歐洲）市場的持續成長。

市場限制：

儘管皮膚強化劑市場前景廣闊，但仍面臨諸多挑戰。高昂的治療費用和有限的健保覆蓋可能會阻礙價格敏感地區潛在用戶的購買意願。此外，潛在的副作用以及維持效果所需的重複治療也可能影響其廣泛應用。各國監管政策的差異以及對仿冒品偽劣產品的擔憂也給相關人員帶來了挑戰。

市場機會：

皮膚強化劑市場蘊藏著巨大的成長潛力。消費者對個人化和先進抗衰老解決方案日益成長的需求，推動了配方和給藥方式的創新。醫療旅遊的蓬勃發展，以及南亞、拉丁美洲和中東等新興市場對皮膚科診所和醫療水療中心投資的增加，進一步提升了市場潛力。化妝品公司與生技公司之間的研發合作，將有助於它們實現產品差異化，並確立市場領先地位。

本報告解答的關鍵問題：

  • 推動全球皮膚強化劑市場成長的關鍵因素有哪些？
  • 哪些地區和細分市場對皮膚滋養產品的需求最高？
  • 原料和輸送技術的創新如何影響市場動態？
  • 皮膚護理產品市場的主要參與者有哪些？他們正在採取哪些策略來保持競爭力？
  • 全球皮膚強化劑市場有哪些新興趨勢和未來預測？

目錄

第1章執行摘要

第2章 市場概覽

  • 市場範圍和定義
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
  • 新冠疫情影響分析
  • 預測因子－相關性和影響

第3章 加值見解

  • 產品採納分析
  • 監管狀態
  • 價值鏈分析
  • PESTLE分析
  • 波特五力分析

第4章 定價分析，2024年

  • 主要亮點
  • 影響每種治療方法費用的關鍵因素
  • 治療方法價格分析

第5章 全球皮膚強化劑市場展望

  • 主要亮點
    • 市場規模（單位）預測
    • 市場規模和年成長率
    • 絕對商機
  • 市場規模與銷售量（單位）分析與預測
    • 2019年至2024年市場規模表現分析
    • 市場規模分析及預測（2025-2032年）
  • 全球皮膚強化劑市場展望（按治療方法分類）
    • 引言/主要發現
    • 按治療方法的市場規模、表現和銷售量（單位）分析，2019-2024 年
    • 按治療方法的市場規模與銷售量（單位）分析與預測，2025-2032 年
      • 美塑療法
      • 微型針
    • 依治療方法進行市場吸引力分析
  • 全球皮膚強化劑市場成分展望
    • 引言/主要發現
    • 按成分分類的市場規模表現分析，2019-2024 年
    • 按成分分類的市場規模分析與預測（2025-2032 年）
      • 透明質酸（HA）
      • 多聚脫氧核苷酸（PDRNs）
      • 聚左旋乳酸(PLLA)/聚右旋乳酸 (PDLLA)
      • 聚己內酯（PCL）
      • 外泌體
    • 市場吸引力分析：成分
  • 全球皮膚強化劑市場展望：性別
    • 引言/主要發現
    • 市場規模表現分析（依性別分類，2019-2024 年）
    • 依性別分類的市場規模分析與預測（2025-2032 年）
      • 女士
      • 男性
    • 市場吸引力分析：按性別分類
  • 全球皮膚強化劑市場展望（依最終用途分類）
    • 引言/主要發現
    • 按應用領域分類的市場規模績效分析（2019-2024 年）
    • 按應用領域分類的市場規模分析與預測（2025-2032年）
      • 醫療水療中心
      • 皮膚科診所
    • 依最終用途進行市場吸引力分析

6. 全球皮膚強化劑市場區域展望

  • 主要亮點
  • 2019年至2024年各地區市場規模表現及銷售量（單位）分析
  • 2025-2032年各地區市場規模及銷售量（單位）分析與預測
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 按地區分類的市場吸引力分析

第7章：北美皮膚強化劑市場展望

8. 歐洲皮膚強化劑市場展望

第9章 東亞皮膚強化劑市場展望

第10章 南亞與大洋洲皮膚強化劑市場展望

第11章：拉丁美洲皮膚強化劑市場展望

12. 中東和非洲皮膚強化劑市場展望

第13章 競爭格局

  • 2024年市佔率分析
  • 市場結構
    • 市場競爭格局分析
    • 競爭對手儀錶板
  • 公司簡介（詳情 - 概述、財務狀況、策略、近期發展）
    • IBM Corporation
    • Teoxane
    • Galderma
    • Merz Pharma
    • Medytox, Inc.
    • ExoCoBio Inc.
    • VAIM Co., Ltd
    • Dexlevo Co., Ltd.
    • AbbVie, Inc（Allergen）
    • PharmaResearch Co., Ltd.
    • Bloomage Biotechnology
    • IBSA Farmaceutici Italia Srl
    • LINKUS GLOBAL Co., Ltd.

第14章附錄

簡介目錄
Product Code: PMRREP35155

Persistence Market Research has recently released a comprehensive report on the global Skin Boosters Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Skin Boosters Market Size (2025E): US$ 1.48 Bn
  • Projected Market Value (2032F): US$ 3.33 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 12.3%

Skin Boosters Market - Report Scope:

The global skin boosters market encompasses innovative aesthetic treatments that involve micro-injections of hyaluronic acid and other biocompatible compounds to improve skin hydration, elasticity, and radiance. These minimally invasive procedures, including mesotherapy and micro-needle techniques, are increasingly adopted by dermatology clinics and med spas worldwide. The rising consumer focus on appearance, anti-aging solutions, and non-surgical cosmetic interventions is driving market expansion.

Market Growth Drivers:

The global skin boosters market is being fueled by several key factors. Increasing awareness about skincare and aesthetic wellness, coupled with rising disposable income, has led consumers to seek minimally invasive cosmetic treatments. Advancements in biocompatible ingredients such as hyaluronic acid, polydeoxyribonucleotides (PDRN), poly-L-lactic acid (PLLA), polycaprolactone (PCL), and exosomes are improving the efficacy and safety of treatments, encouraging wider adoption. Furthermore, growing preference for non-surgical procedures over traditional surgical interventions is contributing to sustained market growth across regions, particularly in North America and Europe.

Market Restraints:

Despite promising growth, the skin boosters market faces challenges. High treatment costs and limited insurance coverage can deter potential users in price-sensitive regions. Additionally, potential side effects and the need for repeated sessions to maintain results may hinder adoption. Regulatory variations across countries, along with concerns regarding counterfeit or low-quality products, also pose challenges for market stakeholders.

Market Opportunities:

The skin boosters market presents significant opportunities for growth. Rising demand for personalized and advanced anti-aging solutions opens avenues for innovation in formulations and delivery methods. Expansion of medical tourism and growing investments in dermatology clinics and med spas in emerging markets such as South Asia, Latin America, and the Middle East offer further potential. Collaborations between cosmetic and biotechnology companies for research and development can drive product differentiation and market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the global skin boosters market's growth?
  • Which regions and market segments are experiencing the highest demand for skin boosters?
  • How are innovations in ingredients and delivery technologies influencing market dynamics?
  • Who are the key players in the skin boosters market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global skin boosters market?

Competitive Intelligence and Business Strategy:

Leading companies in the global skin boosters market, such as Sinclair, Teoxane, Galderma, Merz Pharma, Medytox, Inc., ExoCoBio Inc., VAIM Co., Ltd, Dexlevo Co., Ltd., AbbVie, Inc. (Allergen), PharmaResearch Co., Ltd., Bloomage Biotechnology, IBSA Farmaceutici Italia Srl, and LINKUS GLOBAL Co., Ltd., are investing in product innovation, clinical trials, and strategic partnerships to strengthen their market presence. These companies focus on enhancing product efficacy, safety, and sustainability while expanding distribution networks through dermatology clinics and med spas. Strategic collaborations and research into novel biocompatible compounds are enabling differentiation in an increasingly competitive market.

Companies Covered in This Report:

  • Sinclair
  • Teoxane
  • Galderma
  • Merz Pharma
  • Medytox, Inc.
  • ExoCoBio Inc.
  • VAIM Co., Ltd
  • Dexlevo Co., Ltd.
  • AbbVie, Inc.(Allergen)
  • PharmaResearch Co., Ltd.
  • Bloomage Biotechnology
  • IBSA Farmaceutici Italia Srl
  • LINKUS GLOBAL Co., Ltd.

Market Segmentation

By Therapy Type

  • Mesotherapy
  • Micro-needle

By Ingredient

  • Hyaluronic acid (HA)
  • Polydeoxyribonucleotides (PDRN)
  • Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
  • Polycaprolactone (PCL)
  • Exosomes

By Gender

  • Female
  • Male

By End-use

  • Med Spas
  • Dermatology Clinics

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Skin Boosters Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Therapy Type Costs
  • 4.3. Pricing Analysis, By Therapy Type

5. Global Skin Boosters Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Skin Boosters Market Outlook: Therapy Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Therapy Type, 2019 - 2024
    • 5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy Type, 2025-2032
      • 5.3.3.1. Mesotherapy
      • 5.3.3.2. Micro-needle
    • 5.3.4. Market Attractiveness Analysis: Therapy Type
  • 5.4. Global Skin Boosters Market Outlook: Ingredient
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Ingredient, 2019 - 2024
    • 5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Ingredient, 2025-2032
      • 5.4.3.1. Hyaluronic acid (HA)
      • 5.4.3.2. Polydeoxyribonucleotides (PDRN)
      • 5.4.3.3. Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
      • 5.4.3.4. Polycaprolactone (PCL)
      • 5.4.3.5. Exosomes
    • 5.4.4. Market Attractiveness Analysis: Ingredient
  • 5.5. Global Skin Boosters Market Outlook: Gender
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Gender, 2019 - 2024
    • 5.5.3. Market Size (US$ Bn) Analysis and Forecast, By Gender, 2025-2032
      • 5.5.3.1. Female
      • 5.5.3.2. Male
    • 5.5.4. Market Attractiveness Analysis: Gender
  • 5.6. Global Skin Boosters Market Outlook: End-use
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2019 - 2024
    • 5.6.3. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
      • 5.6.3.1. Med Spas
      • 5.6.3.2. Dermatology Clinics
    • 5.6.4. Market Attractiveness Analysis: End-use

6. Global Skin Boosters Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
  • 6.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Skin Boosters Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 7.2.1. By Country
    • 7.2.2. By Therapy Type
    • 7.2.3. By Ingredient
    • 7.2.4. By Gender
    • 7.2.5. By End-use
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy Type, 2025-2032
    • 7.4.1. Mesotherapy
    • 7.4.2. Micro-needle
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Ingredient, 2025-2032
    • 7.5.1. Hyaluronic acid (HA)
    • 7.5.2. Polydeoxyribonucleotides (PDRN)
    • 7.5.3. Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
    • 7.5.4. Polycaprolactone (PCL)
    • 7.5.5. Exosomes
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By Gender, 2025-2032
    • 7.6.1. Female
    • 7.6.2. Male
  • 7.7. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 7.7.1. Med Spas
    • 7.7.2. Dermatology Clinics
  • 7.8. Market Attractiveness Analysis

8. Europe Skin Boosters Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 8.2.1. By Country
    • 8.2.2. By Therapy Type
    • 8.2.3. By Ingredient
    • 8.2.4. By Gender
    • 8.2.5. By End-use
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy Type, 2025-2032
    • 8.4.1. Mesotherapy
    • 8.4.2. Micro-needle
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Ingredient, 2025-2032
    • 8.5.1. Hyaluronic acid (HA)
    • 8.5.2. Polydeoxyribonucleotides (PDRN)
    • 8.5.3. Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
    • 8.5.4. Polycaprolactone (PCL)
    • 8.5.5. Exosomes
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By Gender, 2025-2032
    • 8.6.1. Female
    • 8.6.2. Male
  • 8.7. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 8.7.1. Med Spas
    • 8.7.2. Dermatology Clinics
  • 8.8. Market Attractiveness Analysis

9. East Asia Skin Boosters Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 9.2.1. By Country
    • 9.2.2. By Therapy Type
    • 9.2.3. By Ingredient
    • 9.2.4. By Gender
    • 9.2.5. By End-use
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy Type, 2025-2032
    • 9.4.1. Mesotherapy
    • 9.4.2. Micro-needle
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Ingredient, 2025-2032
    • 9.5.1. Hyaluronic acid (HA)
    • 9.5.2. Polydeoxyribonucleotides (PDRN)
    • 9.5.3. Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
    • 9.5.4. Polycaprolactone (PCL)
    • 9.5.5. Exosomes
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By Gender, 2025-2032
    • 9.6.1. Female
    • 9.6.2. Male
  • 9.7. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 9.7.1. Med Spas
    • 9.7.2. Dermatology Clinics
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Skin Boosters Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 10.2.1. By Country
    • 10.2.2. By Therapy Type
    • 10.2.3. By Ingredient
    • 10.2.4. By Gender
    • 10.2.5. By End-use
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy Type, 2025-2032
    • 10.4.1. Mesotherapy
    • 10.4.2. Micro-needle
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Ingredient, 2025-2032
    • 10.5.1. Hyaluronic acid (HA)
    • 10.5.2. Polydeoxyribonucleotides (PDRN)
    • 10.5.3. Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
    • 10.5.4. Polycaprolactone (PCL)
    • 10.5.5. Exosomes
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By Gender, 2025-2032
    • 10.6.1. Female
    • 10.6.2. Male
  • 10.7. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 10.7.1. Med Spas
    • 10.7.2. Dermatology Clinics
  • 10.8. Market Attractiveness Analysis

11. Latin America Skin Boosters Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 11.2.1. By Country
    • 11.2.2. By Therapy Type
    • 11.2.3. By Ingredient
    • 11.2.4. By Gender
    • 11.2.5. By End-use
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy Type, 2025-2032
    • 11.4.1. Mesotherapy
    • 11.4.2. Micro-needle
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Ingredient, 2025-2032
    • 11.5.1. Hyaluronic acid (HA)
    • 11.5.2. Polydeoxyribonucleotides (PDRN)
    • 11.5.3. Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
    • 11.5.4. Polycaprolactone (PCL)
    • 11.5.5. Exosomes
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By Gender, 2025-2032
    • 11.6.1. Female
    • 11.6.2. Male
  • 11.7. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 11.7.1. Med Spas
    • 11.7.2. Dermatology Clinics
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Skin Boosters Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 12.2.1. By Country
    • 12.2.2. By Therapy Type
    • 12.2.3. By Ingredient
    • 12.2.4. By Gender
    • 12.2.5. By End-use
  • 12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Therapy Type, 2025-2032
    • 12.4.1. Mesotherapy
    • 12.4.2. Micro-needle
  • 12.5. Market Size (US$ Bn) Analysis and Forecast, By Ingredient, 2025-2032
    • 12.5.1. Hyaluronic acid (HA)
    • 12.5.2. Polydeoxyribonucleotides (PDRN)
    • 12.5.3. Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
    • 12.5.4. Polycaprolactone (PCL)
    • 12.5.5. Exosomes
  • 12.6. Market Size (US$ Bn) Analysis and Forecast, By Gender, 2025-2032
    • 12.6.1. Female
    • 12.6.2. Male
  • 12.7. Market Size (US$ Bn) Analysis and Forecast, By End-use, 2025-2032
    • 12.7.1. Med Spas
    • 12.7.2. Dermatology Clinics
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. IBM Corporation
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Therapy Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Teoxane
    • 13.3.3. Galderma
    • 13.3.4. Merz Pharma
    • 13.3.5. Medytox, Inc.
    • 13.3.6. ExoCoBio Inc.
    • 13.3.7. VAIM Co., Ltd
    • 13.3.8. Dexlevo Co., Ltd.
    • 13.3.9. AbbVie, Inc (Allergen)
    • 13.3.10. PharmaResearch Co., Ltd.
    • 13.3.11. Bloomage Biotechnology
    • 13.3.12. IBSA Farmaceutici Italia Srl
    • 13.3.13. LINKUS GLOBAL Co., Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations